# A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months

> **NCT07036159** · PHASE2 · RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 238 (estimated)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** RTS,S/AS01E vaccine

## Key facts

- **NCT ID:** NCT07036159
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-06
- **Primary completion:** 2027-04-23
- **Final completion:** 2027-04-23
- **Target enrollment:** 238 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07036159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07036159, "A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07036159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*